ZA985140B - Ganglioside immunostimulating complexes and uses thereof - Google Patents

Ganglioside immunostimulating complexes and uses thereof

Info

Publication number
ZA985140B
ZA985140B ZA985140A ZA985140A ZA985140B ZA 985140 B ZA985140 B ZA 985140B ZA 985140 A ZA985140 A ZA 985140A ZA 985140 A ZA985140 A ZA 985140A ZA 985140 B ZA985140 B ZA 985140B
Authority
ZA
South Africa
Prior art keywords
ganglioside
immunostimulating complexes
immunostimulating
complexes
ganglioside immunostimulating
Prior art date
Application number
ZA985140A
Other languages
English (en)
Inventor
John Cooper Cox
Bengt John Lennart Ronnberg
Sigrid Elisabet Sjolander
Original Assignee
Csl Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Csl Ltd filed Critical Csl Ltd
Publication of ZA985140B publication Critical patent/ZA985140B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001184—Cancer testis antigens, e.g. SSX, BAGE, GAGE or SAGE
    • A61K39/001186—MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA985140A 1997-06-12 1998-06-12 Ganglioside immunostimulating complexes and uses thereof ZA985140B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPO7329A AUPO732997A0 (en) 1997-06-12 1997-06-12 Ganglioside immunostimulating complexes and uses thereof

Publications (1)

Publication Number Publication Date
ZA985140B true ZA985140B (en) 1999-01-07

Family

ID=3801620

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA985140A ZA985140B (en) 1997-06-12 1998-06-12 Ganglioside immunostimulating complexes and uses thereof

Country Status (10)

Country Link
US (1) US6814981B1 (ja)
EP (1) EP1019087B1 (ja)
JP (1) JP2002504101A (ja)
AU (1) AUPO732997A0 (ja)
CA (1) CA2293439A1 (ja)
DE (1) DE69838757T2 (ja)
HK (1) HK1026855A1 (ja)
NZ (1) NZ501641A (ja)
WO (1) WO1998056420A1 (ja)
ZA (1) ZA985140B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7713942B2 (en) 2001-04-04 2010-05-11 Nordic Vaccine Technology A/S Cage-like microparticle complexes comprising sterols and saponins for delivery of polynucleotides
EP2011517A1 (en) * 2001-04-04 2009-01-07 Nordic Vaccine Technology A/S Polynucleotide binding complexes comprising sterols and saponin
EP1545605B8 (en) * 2002-10-02 2010-05-26 Nordic Vaccine A/S Composition for vaccination
AU2007322424B2 (en) * 2006-11-20 2013-05-16 Duecom Use of lipid containing particles comprising quillaja saponins for the treatment of cancer
JP2008214241A (ja) * 2007-03-02 2008-09-18 Snow Brand Milk Prod Co Ltd 免疫調節剤

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8205892D0 (sv) * 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
SE8405493D0 (sv) * 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
NZ230747A (en) * 1988-09-30 1992-05-26 Bror Morein Immunomodulating matrix comprising a complex of at least one lipid and at least one saponin; certain glycosylated triterpenoid saponins derived from quillaja saponaria molina
IE912535A1 (en) * 1990-07-27 1992-01-29 Res Dev Foundation Liposomes that Provide Thymic Dependent Help to Weak Vaccine¹Antigens
IL105503A (en) * 1992-04-28 1999-05-09 Astra Ab Carbon peptide couplets capable of eliciting an immune response of T cells
ES2196024T3 (es) 1993-01-22 2003-12-16 Sloan Kettering Inst Cancer Vacunas conjugadas de gangliosido-klh con qs-21.
CA2137638C (en) * 1993-12-09 1999-07-20 Ana M. V. Lopez Anti gangliosides monoclonal antibodies and their use in the specific active immunotherapy of malignant tumors
CU22420A1 (es) * 1993-12-29 1996-01-31 Centro Inmunologia Molecular Composicion vacunal para el desarrollo de una respuesta contra gangliosidos n glicolilados y su uso para el tratamiento del cancer
US6218166B1 (en) * 1994-12-09 2001-04-17 John Wayne Cancer Institute Adjuvant incorporation into antigen carrying cells: compositions and methods
UA56132C2 (uk) * 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини

Also Published As

Publication number Publication date
HK1026855A1 (en) 2000-12-29
JP2002504101A (ja) 2002-02-05
DE69838757T2 (de) 2008-10-30
AUPO732997A0 (en) 1997-07-03
DE69838757D1 (de) 2008-01-03
EP1019087A4 (en) 2003-08-06
NZ501641A (en) 2000-12-22
WO1998056420A1 (en) 1998-12-17
US6814981B1 (en) 2004-11-09
EP1019087A1 (en) 2000-07-19
CA2293439A1 (en) 1998-12-17
EP1019087B1 (en) 2007-11-21

Similar Documents

Publication Publication Date Title
GB2325840B (en) Heater-sensor complex
DE59503739D1 (en) Polymer-sensor
ZA985140B (en) Ganglioside immunostimulating complexes and uses thereof
ZA953003B (en) Connection arrangement
GB2292487B (en) Connection arrangement
GB9405352D0 (en) Henry
GB9421483D0 (en) Mudbug
DE69527047D1 (en) Bisazoverbindung
GB2286644A8 (en) Connection
GB9513600D0 (en) Cavatrox
EP0706238A3 (en) Connection arrangement
GB9419500D0 (en) Stormtent
LTIP2071A (en) Immunostimulating agent
ZA958599B (en) Panel-like structure
KR0112185Y1 (en) Auto-transmission
GB9714582D0 (en) Complex
GB9409634D0 (en) Connecting means
ZA946119B (en) Panels
GB9413539D0 (en) Case
EP0706239A3 (en) Connection device
GB9724706D0 (en) Gyimapet companion
PL100874U1 (en) Shape
AU122897S (en) Cannelloni shape
GB9423135D0 (en) Kick-back-punch
GB9403380D0 (en) Choc-a-par